The Valley Desk

ArticlePaediatric drugsPublished

Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Paediatric drugs
Published
Subject terms
Humans; Colitis, Ulcerative; Inflammatory Bowel Diseases; Crohn Disease; Gastrointestinal Agents; Biological Products; Risk Factors; Adolescent; Child; Child, Preschool; Female; Male
PubMed ID
41060573
PubMed Central ID
PMC12534362
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal